SS&C Technologies Investing Cash Flow increased by 93.9% to -$65.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 3.5%, from -$63.30M to -$65.50M. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows a downward trend with a 72.3% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | -$40.30M | -$90.00M | -$1.58B | -$90.10M | -$34.20M | -$49.80M | -$49.80M | -$64.60M | -$52.70M | -$101.30M | -$50.60M | -$33.40M | -$718.60M | -$53.10M | -$63.30M | -$84.80M | -$81.50M | -$1.08B | -$65.50M |
| QoQ Change | — | — | -123.3% | <-999% | +94.3% | +62.0% | -45.6% | +0.0% | -29.7% | +18.4% | -92.2% | +50.0% | +34.0% | <-999% | +92.6% | -19.2% | -34.0% | +3.9% | <-999% | +93.9% |
| YoY Change | — | — | — | — | — | +15.1% | +44.7% | +96.9% | +28.3% | -54.1% | -103.4% | -1.6% | +48.3% | <-999% | +47.6% | -25.1% | -153.9% | +88.7% | <-999% | -3.5% |